₩112300.00
+
₩1300.00 (1.17%)
End-of-day quote: 05/17/2024
KOSDAQ:A000250
Sam Chun Dang Pharm. Annual Report
| Year | Year | 2023 | 2020 | 2019 | 2016 | 2015 | 2014 | 2013 | 2012 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Rev. | Revenue |
|
₩192.67B | ₩166.86B | ₩186.60B | ₩147.37B | ₩132.06B | ₩118.92B | ₩104.54B | ₩76.65B | |
| GM % | Gross Margin % |
|
50.14% | 56.20% | 59.21% | 53.54% | 54.40% | 54.70% | 53.97% | 49.46% | |
| OM | Operating Margin |
|
4.96% | 2.58% | 13.51% | 16.53% | 15.73% | 15.93% | 15.17% | 7.12% | |
| EPS | Earnings Per Share |
|
₩0.00 | ₩-45.00 | ₩-45.00 | ₩488.00 | ₩413.00 | ₩553.00 | ₩572.00 | ₩449.00 | ₩69.00 |
| Div. | Dividends |
|
₩0.00 | ₩0.00 | ₩50.00 | ₩50.00 | ₩50.00 | ₩75.00 | ₩0.00 | ₩0.00 | |
| PR % | Payout Ratio % |
|
-0.00% | -0.00% | 10.25% | 12.11% | 9.04% | 13.11% | 0 | 0 | |
| Sha. | Shares |
|
22.76m | 22.07m | 21.41m | 21.3m | 20.54m | 20.35m | 19.3m | 19.3m | |
| OCF | Operating Cash Flow |
|
₩23.43B | ₩3.25B | ₩30.60B | ₩17.76B | ₩17.34B | ₩19.55B | ₩15.94B | ₩1.60B | |
| FCF | Free Cash Flow |
|
₩14.71B | ₩-5429.09M | ₩24.01B | ₩13.66B | ₩8.69B | ₩5.42B | ₩11.66B | ₩-1258.04M | |
| FCFS | Free Cash Flow Per Share |
|
₩64.87 | ₩-394.53 | ₩1.00k | ₩424.28 | ₩328.42 | ₩442.67 | ₩582.64 | ₩-93.19 |
